Fluconazole susceptibilities of bloodstream Candida sp. isolates as determined by national committee for clinical laboratory standards method M27-A and two other methods

Journal of Clinical Microbiology

Volumn 37, Issue 7, 1999, Pages 2197-2200

  Cantón, Emilia ^a,b   Pemán, Javier ^b   Carrillo Muñoz, Alfonso ^c   Orero, Ana ^b   Ubeda, Pedro ^b   Viudes, Angel ^b   Gobernado, Miguel ^b  

^a U Bacteriologia Exp Ctro Invest   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c Associacio Catalana d'Intelligencia Artificial   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

AGAR GEL DIFFUSION; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; DILUTION; HUMAN; INCUBATION TIME; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; PARASITE ISOLATION; PRIORITY JOURNAL; STANDARD;

EID: 0033032561     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.7.2197-2200.1999     Document Type: Article

References (22)

1. Barnett, J. A., R. W. Payne, and D. Yarrow. 1990. Yeast: characteristics and identification, 2nd ed. Cambridge University Press, Cambridge, United Kingdom.
2. Barry, A. L., and S. D. Brown. 1996. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol. 34:2154-2157.
3. Bille, J., M. P. Glauser, and the Fluconazole Global Susceptibility Study Group. 1997. Evaluation of the susceptibility of pathogenic Candida species to fluconazole. Eur. J. Clin. Microbiol. Infect. Dis. 16:924-928.
4. Bille, J. 1997. When should Candida isolates be tested for susceptibility to azole antifungal agents? Eur. J. Clin. Microbiol. Infect. Dis. 16:281-282.
5. Cantón, E., J. Pernán, P. Úbeda, A. Pastor, and M. Gobernado. 1997. Actividad in vitro de fluconazol sobre Candida parapsilosis aislados de hemocultivos. Rev. Esp. Quimioter. 10:146-149.
6. Casal, J. B., and N. Pringler. 1991. Antibacterial/antifungal sensitivity testing using Neo-Sensitab, p. 55-58. Rosco Diagnostica, Taastrup, Denmark.
7. Chen, S. C. A., M. L. O'Donell, S. Gordon, and G. L. Gilbert. 1996. Antifungal susceptibility testing using the E-test: comparison with the broth macrodilution technique. J. Antimicrob. Chemother. 37:265-273.
8. Espinel-Ingroff, A., J. L. Rodriguez-Tudela, and J. V. Martínez Suarez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
9. Grant, S. M., and S. P. Clissold. 1990. Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39:877-916.
10. Jarvis, W. R. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
11. Martino, P., C. Girmenia, A. Micozzi, R. Raccah, G. Gentile, M. Venditti, and F. Mandelli. 1993. Fungemia in patients with leukemia. Am. J. Med. Sci. 306:225-232.
12. National Committee for Clinical Laboratory Standards. 1995. Reference method for broth dilution antifungal susceptibility testing of yeast. Tentative standard M27-T. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeast. Approved standard. NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Pfaller, M. A., M. G. Rinaldi, J. N. Galgani, M. B. Bartlett, B. A. Body, A. Espinel-Ingroff, R. A. Fromtling, G. S. Hall, C. E. Hughes, F. C. Odds, and A. M. Sugar. 1990. Collaborative investigation of variables in susceptibility testing of yeast. Antimicrob. Agents Chemother. 34:1648-1654.
15. Pfaller, M. A., B. Dupont, G. S. Kobayashi, J. Müller, M. G. Rinaldi, A. Espinel-Ingroff, S. Shadomy, P. F. Troke, T. J. Walsh, and W. Waenoch. 1992. Standardized susceptibility testing of fluconazole: an international collaborative study. Antimicrob. Agents Chemother. 36:1805-1809.
16. Price, M. F., M. T. LaRocco, and L. O. Gentry. 1994. Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period. Antimicrob. Agents Chemother. 38:1422-1424.
17. Rex, J. H., P. W. Page, V. L. Paetznick, M. Lozano-Chiu, A. Espinel-Ingroff, and E. J. Anaissie. 1998. Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis. Antimicrob. Agents Chemother. 42:129-134.
18. Rodríguez-Tudela, J. L., and J. V. Martínez-Suárez. 1994. Improved medium for fluconazole susceptibility testing of Candida albicans. Antimicrob. Agents Chemother. 38:45-48.
19. Sandven, P., A. Bjørneklett, A. Maeland, and the Norwegian Yeast Study Group. 1993. Susceptibilities of Norwegian Candida albicans strains to fluconazole: emergence of resistance. Antimicrob. Agents Chemother. 37:2443-2448.
20. Sharon, C. A., M. L. O'Donell, S. Gordon, and G. L. Gilbert. 1996. Antifungal susceptibility testing using the E-test: comparison with the broth macrodilution technique. J. Antimicrob. Chemother. 37:265-273.
21. Uzun, Ö., S. Kocagöz, Y. Cetinkaya, S. Arikan, and S. Ünal. 1997. In vitro activity of a new echinocandin, LY 303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates. Antimicrob. Agents Chemother. 41:1156-1157.
22. Yosuji, A., K. Shimizu, H. Araki, K. Fujimaki, N. Nishida, R. Hori, N. Annen, S. Yamamoto, H. Hayakawa, H. Imaizumi, Y. Watanabe, and H. Narita. 1997. T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations. Antimicrob. Agents Chemother. 41:30-34.